437
Participants
Start Date
April 29, 2019
Primary Completion Date
February 16, 2022
Study Completion Date
February 16, 2022
FE 999049 + GnRH agonist (GONAPEPTYL)
Pre-filled injection pen
FE 999049 + GnRH antagonist (CETROTIDE)
Powder and solvent for solution for injection
Das Kinderwunsch Institut Schenk GmbH, Dobl
Kepler University Hospital Linz, Linz
Kinderwunschzentrum Goldenes Kreuz Privatklinik, Vienna
Rigshospitalet, Copenhagen
Hillel Yafe Medical Center, Hadera
Shaare Zedek Medical Center, Jerusalem
Beilinson Hospital Rabin Medical Center, Petah Tikva
Sourasky Medical Center, Tel Aviv
Dipartimento della Donna, del bambino e delle malattie urologiche, Bologna
European Hospital, Roma
St. Elisabeth Ziekenhuis, Tilburg
Isala Fertility Center, Zwolle
Oslo University Hospital, Oslo
Sykehuset Telemark HF, Porsgrunn
Medicus AS, Trondheim
Gyn-A.R.T. AG, Zurich
Lead Sponsor
Ferring Pharmaceuticals
INDUSTRY